Recent research has begun to shed light on the role of LCAT in cancer biology, with findings indicating that LCAT activity may be disrupted in a variety of malignant tumors, potentially affecting tumor progression and response to therapy [4,5,6]. The gene discussed is LCAT; the disease is cancer.